Table 3. Ordered logistic regression analysis for the odds of higher clinical severity of COVID-19 in TB and non-TB patients.
N | Univariable | Multivariable (CC) | Multivariable (MI) | |
---|---|---|---|---|
Characteristic | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
TB patients | 155 | 1.30 (0.09-18.22) | 1.46 (0.20-10.50) | 1.40 (0.16-12.39) |
Age (year) | 155 | 1.02 (0.97-1.06) | 1.01 (1.01-1.01) | 1.01 (1.00-1.02) |
Male | 155 | 1.56 (0.93-2.61) | 2.03 (1.54-2.66) | 1.88 (1.17-3.03) |
Vaccination status | 152 | |||
0 or 1 | Reference | Reference | Reference | |
2 or 3 | 0.90 (0.17-4.84) | 1.81 (0.52-6.36) | 1.41 (0.54-3.64) | |
Comorbidity | 155 | 1.40 (0.85-2.32) | 1.08 (0.73-1.61) | 0.93 (0.55-1.57) |
CT value at diagnosis | 136 | 0.95 (0.89-1.01) | 0.95 (0.90-1.00) | 0.96 (0.90-1.00) |
Omicron (Year 2022) | 155 | 0.39 (0.21-0.73) | 0.21 (0.13-0.33) | 0.25 (0.22-0.29) |
Active case finding | 155 | 0.28 (0.08-1.01) | 0.36 (0.14-0.93) | 0.29 (0.16-0.53) |
CC: Complete case analysis (n=133), CI: confidence interval, MI: multiple imputation analysis, N: number assessed, OR: Odds ratio. Clustered sandwich estimator is used for clustering within two clinics. Goodness-of-fit Hosmer-Lemeshow test: p=0.68, Proportional odds assumption test: p=0.93.